Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR Stock
There is an upward development for Smith & Nephew plc ADR compared to yesterday, with an increase of €0.60 (2.380%).
Pros and Cons of Smith & Nephew plc ADR in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Smith & Nephew plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | 2.380% | -3.077% | -9.353% | 0.800% | -10.000% | -12.500% | -30.000% |
| Smith & Nephew plc | -2.310% | -1.515% | -5.797% | 2.848% | -8.547% | -11.354% | -28.394% |
| Humana Inc. | 1.890% | 4.950% | 23.977% | -5.273% | -3.461% | -56.334% | -44.532% |
| Steris Corp. | -1.210% | 0.000% | -3.649% | -8.900% | -16.422% | 6.270% | 3.229% |
Comments
Smith & Nephew SNATS (SNN) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (NYSE:SNN) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (NYSE:SNN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for SNN provided by MarketBeat